MyFinsight
Home
Blog
About
Proceeds from maturities
of...
$249,140K
(121.06%↑ Y/Y)
Proceeds from sale of
common stock in...
$5,914K
Proceeds from the
issuance of common stock...
$223K
(156.32%↑ Y/Y)
Proceeds from the
issuance of common stock...
$67K
Net cash provided by
(used in) investing...
$52,344K
(239.23%↑ Y/Y)
Net cash provided by
financing activities
$6,176K
(10548.28%↑ Y/Y)
Canceled cashflow
$196,796K
Canceled cashflow
$28K
Net increase
(decrease) in cash, cash...
$8,640K
(111.11%↑ Y/Y)
Canceled cashflow
$49,880K
Purchases of
held-to-maturity investments
$196,161K
(31.33%↑ Y/Y)
Purchases of property and
equipment
$635K
(-31.57%↓ Y/Y)
Stock-based compensation
expense
$11,491K
(54.12%↑ Y/Y)
Accrued expenses and
other liabilities
$4,454K
(14467.74%↑ Y/Y)
Depreciation and impairment
of property and...
$1,660K
(10.45%↑ Y/Y)
Accounts payable
$1,298K
(80.53%↑ Y/Y)
Non-cash operating lease
expense
$385K
(-3.51%↓ Y/Y)
Amortization of finance lease
right-of-use assets
$14K
(-46.15%↓ Y/Y)
Deferred costs related to
offering
$17K
Principal payments on
finance leases
$11K
(-62.07%↓ Y/Y)
Net cash used in
operating activities
-$49,880K
(-23.97%↓ Y/Y)
Canceled cashflow
$19,302K
Net loss
-$65,422K
Operating lease
liabilities
-$1,535K
(-7.12%↓ Y/Y)
Prepaid expenses and
other current assets
$774K
(-18.44%↓ Y/Y)
Amortization and accretion of
premiums/discounts on...
$718K
(-77.70%↓ Y/Y)
Change in contingent
value rights...
-$659K
(-944.87%↓ Y/Y)
Other assets
$74K
(-38.84%↓ Y/Y)
Back
Back
Cash Flow
Neurogene Inc. (NGNE)
Neurogene Inc. (NGNE)
source: myfinsight.com